Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: How does it relate to their recommendations for standard therapy in breast cancer?

Breast

Volumn 8, Issue 4, 1999, Pages 182-187

  Ellis, P M ^a   Buttow, P N ^a   Simes, R J ^b   Tattersall, M H N ^b   Dunn, S M ^b   MacLeod, C ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SURGEON; TREATMENT PLANNING;

EID: 0032826396     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0036     Document Type: Article

References (26)

1. Sackett D L, Rosenberg W M, Muir Gray J A, Haynes R B, Richardson W S. Evidence based medicine: what it is and what it isn't. Br Med J. 312:1996;71-72.
2. Morgan P P. Are physicians learning from what they read in journals. Can Med Assoc J. 133:1985;263.
3. Boissel J P. Impact of randomized clinical trials on medical practices. Control Clin Trials. 10:1989;120S-134S.
4. Ketley D, Woods K L. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 342:1993;891-894.
5. Col N F, McLaughlin T J, Soumerai S B. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study. Arch Intern Med. 156:1996;54-60.
6. Lamas G A, Peeffer M A, Hamm P, Wertheimer J, Rouleau J-L, Braunwald E. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice. N Engl J Med. 327:1992;241-247.
7. Moore M J, O'Sullivan B, Tannock I F. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol. 6:1988;1736-1745.
8. Moore M J, O'Sullivan B, Tannock I F. Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues. Br J Cancer. 62:1990;988-991.
9. Mackillop W J, Palmer M J, O'Sullivan B, Ward G K, Steele R, Dotsikas G. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Br J Cancer. 59:1989;388-395.
10. Palmer M J, O'Sullivan B, Steele R, Mackillop W J. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol. 19:1990;17-28.
11. Raby B, MacKillop W J. Does knowledge guide practice? Another look at the management of non-small cell lung cancer. J Clin Oncol. 13:1995;1904-1911.
12. Stephens R, Gibson D. The impact of clinical trials on the treatment of lung cancer. Clin Oncol. 5:1993;211-219.
13. Lancet. 339:1992;1-15.
14. N Engl J Med. 333:1995;1444-1455.
15. SPSS for Windows: Base system user's guide Release 6.1. 1994;SPSS Inc. Chicago.
16. Kurtz J M. Radiotherapy in the curative treatment of breast cancer: current status and future trends. An opinion sample of radiation oncologists active in breast cancer research. Radiother Oncol. 32:1994;21-28.
17. Auquier A, Rutqvist L, Host H, Rotstein S, Arriagada R. Post-mastectomy megavoltage radiotherapy: the Oslo and Stockholm trials. Eur J Cancer. 28:1992;433-437.
18. Cuzik J, Stewart H, Peto R. Overview of randomised trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 71:1987;15-29.
19. Cuzik J, Stewart H, Rutqvist L. Cause-specific mortality in long term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 12:1994;447-453.
20. NHMRC. Clinical practice guidelines: the management of early breast cancer. Vol. 1. 1995;Australian Government Publishing Service, Canberra.
21. Overgaard M, Hansen S, Overgaard J. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
22. Ragaz J, Jackson S M, Le N. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
23. Brundage M D, Mackillop W J. Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993. J Clin Epidemiol. 49:1996;183-192.
24. Selby P, Gillis C, Haward R. Benefits from specialised cancer care. Lancet. 348:1996;313-318.
25. Davis S, Wright P W, Schulman S F. Participants in prospective, randomised clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials. Cancer. 56:1985;1710-1718.
26. Reiser J, Warner J O. The value of participating in an asthma trial. Lancet. 1985;206-207.